An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
Author:
Kotaki Tomohiro,Kurosu Takeshi,Grinyo Ariadna,Davidson Edgar,Churrotin Siti,Okabayashi Tamaki,Puiprom Orapim,Mulyatno Kris Cahyo,Sucipto Teguh Hari,Doranz Benjamin J.,Ono Ken-ichiro,Soegijanto Soegeng,Kameoka Masanori
Abstract
AbstractDengue virus (DENV), from the genus flavivirus of the family flaviviridae, causes serious health problems globally. Human monoclonal antibodies (HuMAb) can be used to elucidate the mechanisms of neutralization and antibody-dependent enhancement (ADE) of DENV infections, leading to the development of a vaccine or therapeutic antibodies. Here, we generated eight HuMAb clones from an Indonesian patient infected with DENV. These HuMAbs exhibited the typical characteristics of weak neutralizing antibodies including high cross-reactivity with other flaviviruses and targeting of the fusion loop epitope (FLE). However, one of the HuMAbs, 3G9, exhibited strong neutralization ability (NT50 < 0.1 µg/ml) and possessed a high somatic hyper-mutation rate of the variable region, indicating affinity-maturation. Administration of this antibody significantly improved the survival rate of interferon-α/β/γ receptor knockout C57BL/6 mice after a lethal DENV challenge. Additionally, Fc-modified 3G9 molecules that had lost their in vitro ADE activity showed significantly enhanced therapeutic potency in vivo and competed strongly with an ADE-prone antibody in vitro. Taken together, the affinity-matured FLE-targeting antibody 3G9 exhibits several promising features for therapeutic application including a low NT50 value, potential for pan-flavivirus infection treatment, and suppression of ADE. This study demonstrates the therapeutic potency of affinity-matured FLE-targeting antibodies.
Publisher
Cold Spring Harbor Laboratory
Reference67 articles.
1. The continued threat of emerging flaviviruses;Nat. Microbiol,2020
2. Dengue
3. World Health Organization (WHO). Handbook for clinical management of dengue, 2012, Available from: http://www.who.int/denguecontrol/9789241504713/en
4. The global distribution and burden of dengue
5. Current issues in dengue vaccination